secwatch.observer — SEC 8-K summary
======================================

Issuer:     Summit Therapeutics Inc. (SMMT)
CIK:        0001599298
Form:       8-K
Filed at:   2025-06-20T23:59:59+00:00
Accession:  0001599298-25-000120
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Summit Therapeutics sub-subleases 36,406 sq ft Palo Alto office; ~$2.8M annual rent
--------------------------------------------------------------------------------

- Sub-sublease for 36,406 sq ft in Palo Alto, CA, effective June 16, 2025, starting Jan 1, 2026, expiring Oct 28, 2033.
- Annual lease payments average ~$2.8M; term spans nearly 8 years from commencement.
- Agreement conditioned on consent of landlord and sublandlord; will be filed as exhibit to Q2 2025 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1599298/000159929825000120/0001599298-25-000120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1599298/000159929825000120/smmt-20250616.htm
  HTML page:      https://secwatch.observer/filing/0001599298-25-000120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer